Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Lenz, Kimberly J."'
Autor:
Bagwell, Sage, Lavitas, Pavel, Pomfret, Thomas C., Greenwood, Bonnie C., Trask, Nicole M., Tran, Stephanie, Schiff, Nancy L., Hydery, Tasmina, Leto, Patricia, Price, Mylissa K., Alper, Caroline J., Lenz, Kimberly J., Jeffrey, Paul L.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f9e81920c98dca9ede43060b973c9d3b
Autor:
Leo, Sam M., Lowe, Maria M., Alper, Caroline J., Lee, Karen W., Lenz, Kimberly J., Liou, Gloria, Pomfret, Thomas C., Price, Mylissa K., Tesell, Mark A., Jeffrey, Paul L.
BACKGROUND: Ivacaftor is the first Food and Drug Administration-approved medication to treat an underlying genetic defect in patients with cystic fibrosis (CF). With an approximate annual cost of $300,000 per patient, ivacaftor may have a profound fi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff575ba797c1ce101713b4947a53e149